Previous Article | Next Article 
Infection and Immunity, February 2000, p. 877-883, Vol. 68, No. 2
0019-9567/00/$04.00+0
A Mycobacterium ulcerans Toxin,
Mycolactone, Causes Apoptosis in Guinea Pig Ulcers and Tissue
Culture Cells
Kathleen M.
George,
Lisa
Pascopella,
Diane M.
Welty, and
P. L. C.
Small*
Microscopy Branch, National Institute of
Allergy and Infectious Diseases, National Institutes of Health,
Rocky Mountain Laboratories, Hamilton, Montana 59840
Received 15 September 1999/Accepted 27 October 1999
 |
ABSTRACT |
Mycobacterium ulcerans is the causative agent of Buruli
ulcer, a tropical ulcerative skin disease. One of the most intriguing aspects of this disease is the presence of extensive tissue damage in
the absence of an acute inflammatory response. We recently purified and
characterized a macrolide toxin, mycolactone, from M. ulcerans. Injection of this molecule into guinea pig skin
reproduced cell death and lack of acute inflammatory response similar
to that seen following the injection of viable bacteria. We also showed
that mycolactone causes a cytopathic effect on mouse fibroblast L929
cells that is characterized by cytoskeletal rearrangements and growth
arrest within 48 h. However, these results could not account for
the extensive cell death which occurs in Buruli ulcer. The results
presented here demonstrate that L929 and J774 mouse macrophage cells
die via apoptosis after 3 to 5 days of exposure to mycolactone.
Treatment of cells with a pan-caspase inhibitor can inhibit
mycolactone-induced apoptosis. We demonstrate that injection of
mycolactone into guinea pig skin results in cell death via
apoptosis and that the extent of apoptosis increases as the lesion
progresses. These results may help to explain why tissue damage
in Buruli ulcer is not accompanied by an acute inflammatory response.
 |
INTRODUCTION |
Mycobacterium ulcerans is
the causative agent of a tropical skin disease called Buruli ulcer
(18), which has recently been recognized as an emerging
infection in West Africa (12). Buruli ulcer patients present
with indolent, necrotizing ulcerative lesions. The ulcers are
characterized by extensive necrosis of the skin and underlying fat.
Erythema and focal necrosis, including vascular erosion, are also
present. In contrast to other pathogenic mycobacterial diseases such as
tuberculosis, there is little evidence of an early acute inflammatory
response to the infection, and the bacteria are primarily
extracellular. Although the lesions may be quite extensive, covering up
to 15% of a patient's skin surface, they are relatively painless.
We have recently purified and characterized a polyketide toxin from
M. ulcerans and termed this mycolactone (10).
When added to the mouse fibroblast cell line L929, the toxin causes 90 to 100% of the adherent cells to undergo cytoskeletal rearrangement, subsequently rounding up and detaching from the tissue culture plate
within 24 to 36 h of treatment. This has been termed the cytopathic effect (CPE) (9, 15, 25). The toxin also causes an arrest in the G0/G1 phase of the cell cycle
within 48 h (9, 10). More importantly, mycolactone,
when injected intradermally into guinea pigs, is capable of causing a
lesion similar to that produced by whole organisms (10). An
isogenic mutant which does not produce the toxin is not virulent in the
guinea pig model. Taken together, these data provide strong evidence
that mycolactone plays a pivotal role in Buruli ulcer pathogenesis.
Necrotic areas in infected guinea pig skin contain many pyknotic
nuclei, a finding suggestive of apoptosis. It is impossible to
determine by hematoxylin-eosin staining whether these cells are
resident or infiltrated immune cells killed at the site of the lesion.
In addition, the mechanism of cell death is unknown. To begin to
identify the mechanism underlying the histopathology observed in the
guinea pig lesions, we decided to look closer at mechanisms of cell
death, such as apoptosis.
The cell death apparent in mycolactone-induced guinea pig lesions is at
odds with the observation that mycolactone causes growth arrest, with
little reduction in viability, in L929 cells. To address the
possibility that mycolactone can induce cell death in tissue culture
cells with delayed kinetics, we extended the length of time of the
cytopathology assay. We also included a macrophage-like cell line,
J774, in our experiments to study the possible immune regulatory
functions of the toxin. J774 cells exhibit a similar cytopathology to
that of L929 cells. A total of 90 to 100% of cells exhibit
cytoskeletal rearrangements within 24 to 36 h of treatment and
undergo growth arrest. In addition, 24-h pretreatment of J774 cells
with toxin inhibits induction of the proinflammatory cytokines, tumor
necrosis factor alpha (TNF-
), and interleukin-1 (IL-1) in response
to lipopolysaccharide stimulation (L. Pascopella, unpublished results).
We have used here both in vivo and in vitro studies to determine the
mechanism of cell death mediated by mycolactone. We demonstrate that
apoptotic cells reside in the area of necrosis of the guinea pig
lesions infected with either M. ulcerans organisms or the toxin alone. This area of necrosis with apoptosis increases with time,
indicating that apoptosis may play a role in Buruli ulcer pathology
and, in particular, the lack of inflammation. We also show that the
toxin does cause cell death in L929 and J774 cells, with delayed
kinetics. Using the TUNEL (terminal
deoxynucleotidyltransferase-mediated dUTP-biotin nick end
labeling) reaction and genomic DNA analysis, we show that the toxin can
cause apoptosis to occur in the two cell lines. Treating the L929 cells
with a caspase inhibitor prevents apoptosis, but not cytopathology,
suggesting that apoptosis may be a secondary, rather than primary,
effect of the toxin on tissue culture cells.
 |
MATERIALS AND METHODS |
Eukaryotic cell culture.
L929 mouse fibroblast cells (ATCC
CCL1) and mouse macrophage cells J774A.1 (ATCC TIB 67) were purchased
from the American Type Culture Collection and passaged in Dulbecco
modified Eagle medium supplemented with 10% heat-inactivated fetal
calf serum (Gibco BRL, Grand Island, N.Y.).
Preparation of mycolactone.
M. ulcerans 1615 (ATCC
35840) cells were passaged as described elsewhere (9).
Mycolactone was prepared as described previously (10).
Briefly, late-exponential-phase M. ulcerans bacteria were harvested and extracted with chloroform-methanol (2:1 [vol/vol]) for
2 h at room temperature. The cell debris was separated from the
organic phase by centrifugation, and a Folch extraction was performed
by the addition of 0.2 volumes of water. The organic phase was dried
down and resuspended in a small volume of ice-cold acetone. Mycolactone
was purified from the acetone-soluble fraction on a preparative
thin-layer chromatography plate (Whatman Pk6F Silica Gel 60; Alltech,
Deerfield, Ill.) developed in chloroform-methanol-water (90:10:1
[vol/vol]). Mycolactone runs at an Rf of 0.23 in this solvent system. Mycolactone was eluted from the silica plate in running buffer and weighed, and the effective dose was determined (see
below) (9).
Guinea pig skin model of infection.
Hartley female guinea
pigs were prepared for intradermal injection by shaving the backs of
the animals and anesthetizing them. M. ulcerans bacteria was
used at an inoculum of 107 (confirmed by viable plate
counting). Bacteria were passed five times through a 25-gauge needle to
approximate a uniform suspension. Mycolactone was air dried,
resolubilized in a small amount of ethanol, and diluted in
mycobacterial medium (Middlebrook 7H9 with OADC supplement). As a
negative control, mycobacterial medium was injected. Injections were
done with final volumes of 100 µl. All animal experiments were
conducted according to the guidelines of the Animal Care and Use
Committee at Rocky Mountain Laboratories. Guinea pigs were observed
daily for signs of gross pathology and were sacrificed at days 2, 8, and 22 postinjection. Lesions were excised and fixed for 24 h in
3.7% formaldehyde. Samples were embedded in paraffin, cut into 4-µm
sections, and stained with hematoxylin-eosin.
TUNEL reaction on guinea pig sections.
Paraffin-embedded
guinea pig sections were dewaxed with xylenes and rehydrated through an
ethanol series. TUNEL reactions were performed with the In Situ Cell
Death Detection POD Kit (Boehringer Mannheim, Indianapolis, Ind.). The
sections were treated with 10 µg of proteinase K (Sigma) per ml (15 min at room temperature); endogenous peroxidase was then blocked with
0.3% hydrogen peroxide-phosphate-buffered saline (PBS) (30 min at room
temperature) and permeabilized with 0.1% Triton X-100 (2 min on ice).
The TUNEL reaction proceeded for 60 min at 37°C with CO2.
After a washing with PBS, the slides were incubated with the
Converter-POD at a 1:2 dilution in a Tris-NaCl buffer (30 min at 37°C
with 5% CO2). For diaminobenzidene (DAB) detection, the
slides were incubated with DAB substrate (10 min at room temperature).
After staining with hematoxylin, the slides were dehydrated and
mounted. For negative controls, the TUNEL reaction was performed on
mycobacterial-medium-injected guinea pig skin sections and on M. ulcerans- and mycolactone-treated sections without terminal
transferase enzyme.
Cytotoxicity assay.
L929 and J774 cells were plated at
2 × 104 in 24-well tissue culture plates and allowed
to adhere overnight at 37°C with CO2. The next day,
mycolactone was dissolved in ethanol and diluted in tissue culture
media to the appropriate concentration and added to wells. As a
control, ethanol was diluted similarly in tissue culture medium and
added to the wells. At the indicated times, triplicate wells of each
concentration of mycolactone or control cells were harvested by
removing the supernatant, washing with PBS, and removing the adherent
cells with trypsin followed by a PBS wash. Adherent and nonadherent
cells were pooled and tested for presence of dead cells by ethidium
homodimer uptake with the Live/Dead Viability/Cytoxicity Kit (Molecular
Probes, Inc., Eugene, Oreg.). Five fields of stained cells were
visualized on a Bio-Rad MRC 1000 laser confocal microscope. The percent
dead and standard error of the mean values were calculated by using
StatView 4.51 software (Abacus Concepts).
TUNEL reaction on L929 and J774 cells.
Cells were plated and
allowed to adhere overnight. The next day, 300 ng of mycolactone (or an
equivalent amount of ethanol diluted in tissue culture media for the
negative control) was added, and both adherent and nonadherent cells
were harvested and pooled together at the indicated times. The TUNEL
reaction was performed by using the Promega Cell Death kit (Promega,
Madison, Wis.). Briefly, the cells were fixed with 4%
paraformaldehyde-PBS (20 min at 4°C). After a PBS wash, the cells
were permeabilized with 0.2% Triton X-100-PBS, and the TUNEL reaction
proceeded at 37°C with 5% CO2. The reaction was stopped
by washing the cells in 2× SSC (1× SSC is 0.15 M NaCl plus 0.015 M
sodium citrate). The percentage of TUNEL-positive cells was determined
by counting fluorescent cells in at least five fields. Fluorescence and
phase pictures were taken on a Nikon Eclipse TE3000 inverted microscope with an Epi-fluorescence attachment (Nikon, Inc., Melville, N.Y.).
DNA fragmentation assay.
In the DNA fragmentation assay,
106 L929 or J774 cells were plated and allowed to adhere
overnight at 37°C with 5% CO2. The next day, 300 ng of
mycolactone (or an equivalent amount of ethanol diluted in tissue
culture medium for control cells) per ml was added. At the indicated
times, adherent and nonadherent cells were harvested, combined, washed
with PBS, and lysed in 0.4 ml of lysis buffer (20 mM Tris, pH 8.0; 4 mM
EDTA; 0.4% Triton X-100; 20 µg of proteinase K per ml; for 20 min at
room temperature). Cell debris was separated by centrifugation, and the
lysate was extracted with phenol-chloroform-isoamyl alcohol (25:24:1
[vol/vol]) twice and ethanol precipitated. The DNA pellet was
resuspended in TE plus 10 µg RNase A (30 min at 37°C) per ml. DNA
was run on a 1.5% agarose gel, stained with ethidium bromide, and
photographed. Control cells were harvested at day 5.
Caspase inhibitor assay.
Mycolactone or (ethanol diluted in
tissue culture medium for control cells) was added to L929 cells at 300 ng/ml. Boc-Asp-(Ome)-fluoromethylketone (B-D-FMK) (Enzyme Systems
Products, Livermore, Calif.), a general inhibitor of caspases, was
resuspended in dimethyl sulfoxide (DMSO) at 100 mM. At the same time as
the addition of mycolactone, B-D-FMK was added at 1 µM. Control cells
were treated with the same percentage of DMSO (0.001%). Due to the
length of the assay and the short half-life of B-D-FMK, the caspase
inhibitor was re-added every day. Adherent and nonadherent cells were
harvested at each time point, and the TUNEL reaction was performed as
described above. Cells were observed microscopically each day and
scored as CPE positive when 90 to 100% of cells were rounded and
detached. In preliminary experiments, concentrations of B-D-FMK were
titrated; 1 µM was the most effective concentration for inhibiting
apoptosis without causing toxicity to L929 cells (data not shown).
 |
RESULTS |
M. ulcerans organisms and mycolactone cause apoptosis
in guinea pig skin.
The extensive tissue destruction and presence
of cells with pyknotic nuclei present in M. ulcerans-infected lesions suggests that apoptosis may be relevant
to the pathogenesis of M. ulcerans. We performed the TUNEL
assay on M. ulcerans-infected guinea pig sections 8 days
postinjection and found TUNEL-positive nuclei throughout the section
(Fig. 1F). An area of early adipocyte destruction, edema, and some
vascular disruption could be seen (Fig. 1D to F). As a negative control, mycobacterial
medium-treated guinea pig skin was assayed by the TUNEL reaction and
very few, if any, TUNEL-positive cells were detected (Fig. 1C). As a
second negative control, the TUNEL reaction was also performed on
M. ulcerans- and mycolactone-induced lesions in the absence
of terminal transferase enzyme, and no positive nuclei were detected
(data not shown), indicating that the TUNEL-positive reactions were not
due to endogenous peroxidase activity. Next, we performed TUNEL assays
on tissue sections from mycolactone-treated guinea pig lesions at
different time points postinoculation. Controls were as shown and
described in Fig. 1. Guinea pig lesions induced by 100 µg of
mycolactone at 2, 8, or 22 days postinoculation (p.i.) were analyzed
(10). Apoptotic cells were present in the necrotic areas at
all timepoints (Fig. 2), and the area of
apoptosis increased over time as the size of the lesion and extent of
destruction grew. At all time points, the region of apoptosis was
centered around the point of injection, indicating that the toxin was
acting locally to mediate the destruction and apoptosis. At 2 days
p.i., tissue destruction was in its early stages (Fig. 2A to C).
Apoptotic endothelial cells were present around apparently intact blood vessels (Fig. 2C). Infiltrated cells, possibly monocytes, were also
apoptotic (Fig. 2C). At 8 days p.i., the tissue destruction was more
apparent. Necrosis was apparent in the adipose, muscle, and underlying
areas. Blood vessels show leakage into the muscle layer, presumably
from microhemorrhages (Fig. 2D to F). Apoptosis was present throughout
the necrotic area. The area of edema between adipocytes and muscle with
primarily apoptotic cells can be seen (Fig. 2F). At 22 days p.i.,
tissue destruction was massive (Fig. 2G to I). Edema and calcification
were apparent, as well as disrupted blood vessels. All nuclei
surrounding the blood vessel were apoptotic (Fig. 2I). The
toxin-induced lesions progressed much more rapidly than the
bacterium-induced lesions and were more localized around the point of
inoculation. There also appeared to be more TUNEL-positive cells in the
mycolactone-treated lesions than in the M. ulcerans-infected lesions. These observations can be explained by a more dramatic, although physiological, response to the purified toxin.

View larger version (81K):
[in this window]
[in a new window]
|
FIG. 1.
Detection of apoptosis in M. ulcerans-infected guinea pig lesions and media controls. The TUNEL
reaction was performed, detected by use of DAB, and counterstained with
hematoxylin as described in Materials and Methods. A to C, negative
control section injected with mycobacterial medium; D to F, M. ulcerans-injected section (8 days postinjection). A and D, ×83;
B, C, E, and F, ×332. Panels A, B, D, and E are
hematoxylin-eosin-stained sections; panels C and F are TUNEL sections.
Arrows point to the blood vessels; muscle cells (m) are also
indicated.
|
|

View larger version (111K):
[in this window]
[in a new window]
|
FIG. 2.
Detection of apoptosis in mycolactone-induced guinea pig
lesions. The TUNEL reaction was performed, detected by use of DAB, and
counterstained with hematoxylin-eosin as described in Materials and
Methods. The mycobacterial-medium control is shown in panels A to C of
Fig. 1. A to C, 2 days p.i.; D to F, 8 days p.i; G to I, 22 days p.i.
Magnifications: A, D, and G, ×83; B, C, E, F, H, and I, ×332. Panels
A, B, D, E, G, and H are hematoxylin-eosin-stained sections; panels C,
F, and I are TUNEL sections. Arrows point to blood vessels; muscle (m),
adipocytes (a), and calcification (c) are also indicated.
|
|
Mycolactone-induced cell death of L929 and J774 cells.
Several
characterized bacterial toxins are capable of causing cell cycle arrest
followed by delayed cell death (6, 31), and we hypothesized
that mycolactone may also cause a delayed cell death on L929 cells. We
treated L929 cells with increasing concentrations of mycolactone and
assayed for cell death by ethidium homodimer uptake. A wide range of
concentrations of mycolactone (3 ng/ml to 3 µg/ml, which corresponds
to approximately 4 nM to 4 µM) caused significant cell death of L929
cells after 3 days of treatment (Fig.
3A). Concentrations at or below 300 pg/ml
had no effect on cell viability. It is important to note that all concentrations of mycolactone which caused cell death also caused an
identical CPE (90 to 100% of cells rounding and growth arrest within
48 h).

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 3.
Mycolactone-mediated cell death of L929 and J774 cells.
(A) Cytoxicity on L929 cells. L929 cells were treated with mycolactone
at 30 pg/ml (hatched squares), 300 pg/ml (open triangles), 3 ng/ml
(hatched diamonds), 30 ng/ml (open diamonds), 300 ng/ml (hatched
circles), 3 µg/ml (open circles), or ethanol alone (open squares).
(B) Cytoxicity on J774 cells. J774 cells were treated with mycolactone
at 300 pg/ml (open triangles), 30 ng/ml (open diamonds), 3 µg/ml
(open circles), or ethanol alone (open squares). Cell death was
measured by ethidium homodimer uptake as described in Materials and
Methods.
|
|
The lack of an acute inflammatory response and the paucity of
peripheral mononuclear cells in
M. ulcerans- and
mycolactone-induced
lesions raises several interesting hypotheses. The
toxin may directly
kill macrophages, or it may inhibit their chemotaxis
toward the
lesion. To address the former possibility, we tested a mouse
macrophage
cell line J774 to determine whether mycolactone mediates
cell
death in a manner similar to fibroblasts. J774 cells, like L929
cells, displayed similar morphological changes and dose dependence,
although the kinetics of cell death were accelerated in comparison
(Fig.
3B). Like L929 cells, the J774 line was affected at
concentrations
above 300 pg/ml. All concentrations of mycolactone which
caused
cell death in J774 cells also caused identical CPE, as in the
L929
cells.
TUNEL assay and genomic DNA analysis.
To determine whether
mycolactone causes death by apoptosis, we assayed mycolactone-treated
L929 and J774 cells for DNA fragmentation by TUNEL and gel
electrophoresis assays. At 3 days after treatment, L929 cells reacted
positively in TUNEL assays (Fig. 4B).
J774 cells reacted positively after 2 days treatment with mycolactone (Fig. 4D). Control cells were negative by the TUNEL assay. A kinetic analysis of the percentage of cells positive by this assay indicated that apoptosis occurred with slightly different kinetics in the two
cell lines, occurring after 2 days of treatment in the macrophage cell
line as opposed to after 3 days of treatment for the fibroblasts (Fig.
5).

View larger version (82K):
[in this window]
[in a new window]
|
FIG. 4.
TUNEL reaction of L929 and J774 cells. (A and B) The
TUNEL reaction was performed on L929 cells treated with mycolactone at
300 ng/ml for 3 days. (C and D) TUNEL reaction was performed on J774
cells treated with mycolactone at 300 ng/ml for 3 days. Panels A and C
are phase-contrast micrographs, and panels B and D are fluorescence
micrographs. Arrows in panels A and C identify the TUNEL-positive
cells.
|
|

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 5.
Quantitation and kinetic analysis of apoptotic L929 and
J774 cells. The TUNEL reaction was performed on L929 (A) and J774 (B)
cells and quantitated as described in Materials and Methods. Symbols:
, control (ethanol-treated) cells; , mycolactone-treated cells.
|
|
The ability of mycolactone to induce apoptotic-like DNA fragmentation
was confirmed by extraction of whole genomic DNA from
treated cells and
electrophoresis on agarose gels. L929 cells
showed the characteristic
DNA laddering of apoptotic cells after
3 days of treatment
(Fig.
6). J774 DNA was analyzed at day 2 and
day 3 posttreatment with
mycolactone, corresponding to the days
with the highest percentage of
TUNEL-positive cells. We were unable
to detect laddering of J774 DNA
with this assay, even though the
experiment was repeated several times.
Instead, the DNA appeared
degraded compared to the control
(ethanol-treated) cells (Fig.
6).

View larger version (113K):
[in this window]
[in a new window]
|
FIG. 6.
Electrophoretic analysis of DNA from L929 and J774 cells
exposed to mycolactone. Genomic DNA was extracted from cells treated
with 300 ng of mycolactone per ml and electrophoresed on a 1.5%
agarose gel. Lane M, molecular weight markers; lane C, control L929
cells (treated with ethanol and harvested at day 5). Numbers above the
lanes indicate days of treatment with mycolactone.
|
|
Inhibition of apoptosis in L929 cells.
The lag time between
the CPE (cytoskeletal rearrangement) and apoptosis led us to ask
whether the two events are interdependent. We hypothesized that, by
inhibiting apoptosis, we may alter either the kinetics or the severity
of the CPE.
Inhibitors of the IL-1

-converting enzyme family of caspases have
been shown to inhibit apoptosis (
20,
27,
32). A pan-caspase
inhibitor, B-D-FMK, was used to inhibit apoptosis of
mycolactone-treated
L929 cells. B-D-FMK was added to L929 cells at the
same time as
mycolactone and re-added daily (due to inactivation by
endogenous
cysteine proteases). Cells were analyzed microscopically for
CPE
as defined in Materials and Methods and then harvested and
processed
for TUNEL reaction. L929 cells treated with mycolactone and
B-D-FMK
show normal CPE, but B-D-FMK inhibits progression to apoptosis
compared to the mycolactone-treated L929 cells. B-D-FMK treatment
alone
caused no CPE and did not induce apoptosis (Fig.
7). We
then asked whether inhibition of
apoptosis by B-D-FMK would change
the cell death phenotype by assaying
for ethidium homodimer uptake.
There was no difference in either the
kinetics of cell death or
the percentage of dead cells regardless of
whether or not B-D-FMK
was added to the mycolactone-treated cells (data
not shown). This
finding indicates that if apoptosis is inhibited, the
mycolactone-treated
cells die by necrosis.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 7.
B-D-FMK inhibits mycolactone-induced apoptosis. L929
cells were treated with ethanol only ( ), 1 µM B-D-FMK only ( ),
mycolactone only ( ), or mycolactone plus B-D-FMK ( ). Cells were
harvested at each day and processed for the TUNEL reaction.
|
|
 |
DISCUSSION |
Previous work from our laboratory demonstrated that the M. ulcerans polyketide toxin, mycolactone, causes Buruli ulcer-like lesions in a guinea pig model of infection (10, 25). These lesions are characterized by extensive cell damage with many cells containing pyknotic nuclei. Mycolactone also causes a CPE on L929 cells
within 48 h of treatment (defined as 90 to 100% of cells exhibiting cytoskeleton rearrangements and growth arrest), with minimal
loss of viability after 48 h. To resolve the apparent paradox of
the two phenotypes and to begin to define the mechanism underlying the
histopathology, we looked at cell death in both systems.
To determine the relevance of apoptosis to pathology, we performed
TUNEL assays on M. ulcerans- and mycolactone-induced guinea pig lesions and found that apoptotic cells were present in the lesions.
By studying mycolactone-induced lesions over time postinjection, it was
apparent that the area of apoptosis increased over time as the size of
the lesion increased. Not all pyknotic nuclei were TUNEL positive. One
explanation for this finding is that not all cell death is apoptosis
mediated. An alternative hypothesis is that apoptosis is the primary
cause of cell death but that at any given time point not all cells in
the lesion are TUNEL positive. Due to the dearth of guinea pig
cell-specific markers, we have not definitely identified affected cells
in the lesions.
We have demonstrated here that longer exposure to the toxin causes cell
death of L929 cells within 72 h across a wide range of mycolactone
concentrations. J774 cells show a similar dose dependence of
mycolactone and a cell death by 48 h, which is slightly earlier
than for the L929 cells. Using TUNEL and DNA fragmentation assays, we
showed that mycolactone induced apoptosis coincident with cell death.
It is important to note that both the J774 and L929 cultures show 90 to
100% cytopathicity but that the percentage of TUNEL-positive cells
over a period of days showed a maximum of 20 to 35% undergoing
apoptosis. Cytopathicity and apoptosis may be two independent primary
events, with apoptosis affecting only a subset of the population.
Another hypothesis is that apoptosis is a secondary result of the CPE.
Inhibition of anchorage-dependent cell spreading has been shown to
trigger apoptosis (8, 24, 30), as have fungal metabolites,
such as cytochalasins, which effect actin polymerization (28,
30). By using a pan-caspase inhibitor, we showed that mycolactone
is capable of causing a CPE in L929 cells without progression to
apoptosis, demonstrating that the CPE is not dependent on apoptosis.
Although the mycolactone-treated L929 cells reproducibly showed a
strong DNA fragmentation pattern, we were unable to demonstrate DNA
fragmentation with J774 cells despite repeated attempts. There is much
information in the literature describing apoptosis occurring without
the presence of DNA ladder formation (5, 21, 22, 29).
Perhaps the window of time that the DNA ladder would appear in J774
cells was too narrow for us to detect and, therefore, the DNA appeared
intact, as in control cells, or degraded, as in mycolactone-treated cells.
Mycolactone is a complex polyketide-derived macrolide. Macrolides are
broadly characterized into groups based on the number of carbons
present in the lactone ring (4). Mycolactone is a
12-membered ring macrolide which is the group of macrolides containing
the smallest lactone ring. Other 12-membered ring macrolides include
methymycin, litorin, patulolide, cladospolide, and recefeiolide (4). Although they share a similar lactone ring size, the
rest of their chemical structures bear little resemblance to
mycolactone, and no biological activity has been assigned for them
approximating the activity we have observed here with mycolactone.
Other macrolides that induce apoptosis in tissue culture cells include
erythromycin, bafilomycin A1, antimycin A, and ionomycin (1-3,
11, 13, 17). The concentrations of these macrolides used to
induce apoptosis are between 60 ng/ml and 6 µg/ml, which is the
mycolactone concentration range in which we observe similar effects.
These examples may or may not be relevant to mycolactone-mediated
apoptosis. Whether mycolactone exerts its effects by any of these
mechanisms is currently under investigation.
Pathogenic mycobacteria, such as M. tuberculosis, have been
shown to induce apoptosis in cultured monocytes (14, 19). Further analysis of the mycobacterial products which may regulate apoptosis demonstrated that culture filtrate of M. tuberculosis, supernatant from heat-treated organisms, and
purified protein derivative induce apoptosis (16, 26).
Whether these extracts contain any mycolactone-like molecules is
possible but as yet unknown.
The most distinctive and unique feature of M. ulcerans
pathology is the presence of cell damage in the absence of an acute inflammatory response. Why does this cell death not lead to an acute
inflammatory response? The data presented here suggest a hypothesis for
how mycolactone as a single molecule might lead to this property.
Recently, it has been shown that mycolactone suppressed the production
of inflammatory cytokines (23). These data could explain why
neutrophils are absent at early time points following infection. The
results presented here from both in vitro and in vivo experiments
suggest that cell death results from apoptosis. Apoptosis as a
phenomenon is associated with a lack of inflammatory response
(7). If apoptosis is a major cause of pathology in Buruli
ulcer, this could explain why an acute inflammatory reaction does not
develop in these lesions despite extensive cell damage.
 |
ACKNOWLEDGMENTS |
We thank R. Wells and C. Favara for excellent technical
assistance. We also thank L. Barker, T. Hackstadt, L. Perry, J. Portis, and J. Van Putten for critical reading of the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Microscopy
Branch, NIAID/NIH, Rocky Mountain Laboratories, 903 S 4th
St., Hamilton, MT 59840. Phone: (406) 363-9280. Fax: (406) 363-9371. E-mail: psmall{at}niaid.nih.gov.
Editor:
T. R. Kozel
 |
REFERENCES |
| 1.
|
Aagaard-Tillery, K. M., and D. F. Jelinek.
1994.
Inhibition of human B lymphocyte cell cycle progression and differentiation by rapamycin.
Cell. Immunol.
156:493-507[CrossRef][Medline].
|
| 2.
|
Aagaard-Tillery, K. M., and D. F. Jelinek.
1995.
Differential activation of a calcium-dependent endonuclease in human B lymphocytes. Role in ionomycin-induced apoptosis.
J. Immunol.
155:3297-3307[Abstract].
|
| 3.
|
Aoshiba, K.,
A. Nagai, and K. Konno.
1995.
Erythromycin shortens neutrophil survival by accelerating apoptosis.
Antimicrob. Agents Chemother.
39:872-877[Abstract].
|
| 4.
|
Bryskier, A.,
C. Agouridas, and J.-C. Gasc.
1993.
Classification of macrolide antibiotics, p. 5-66.
In
A. J. Bryskier, J.-P. Butzler, H. C. Neu, and P. M. Tulkens (ed.), Macrolides: chemistry, pharmacology and clinical uses. Arnette S.A., Paris, France.
|
| 5.
|
Cohen, G. M.,
X.-M. Sun,
R. T. Snowden,
D. Dinsdale, and D. N. Skilleter.
1992.
Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation.
Biochem. J.
286:331-334.
|
| 6.
|
De Rycke, J.,
P. Mazars,
J.-P. Nougayrede,
C. Tasca,
M. Boury,
F. Herault,
A. Valette, and E. Oswald.
1996.
Mitotic block and delayed lethality in HeLa epithelia cells exposed to Escherichia coli BM2-1 producing cytotoxic necrotizing factor type 1.
Infect. Immun.
64:1694-1705[Abstract].
|
| 7.
|
Dini, L.,
M. T. Ruzittu, and L. Falasca.
1996.
Recognition and phagocytosis of apoptotic cells.
Scanning Microsc.
10:239-252[Medline].
|
| 8.
|
Fukai, F.,
M. Mashimo,
K. Akiyama,
T. Goto,
S. Tanuma, and T. Katayama.
1998.
Modulation of apoptotic cell death by extracellular matrix proteins and a fibronectin-derived antiadhesive protein.
Exp. Cell Res.
242:92-99[CrossRef][Medline].
|
| 9.
|
George, K. M.,
L. P. Barker,
D. M. Welty, and P. L. C. Small.
1998.
Partial purification and characterization of biological effects of a lipid toxin produced by Mycobacterium ulcerans.
Infect. Immun.
66:587-593[Abstract/Free Full Text].
|
| 10.
|
George, K. M.,
D. Chatterjee,
G. Gunawardana,
D. Welty,
J. Hayman,
R. Lee, and P. L. C. Small.
1999.
Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence.
Science
283:854-857[Abstract/Free Full Text].
|
| 11.
|
Grand, R. J. A.,
A. E. Milner,
T. Mustoe,
G. D. Johnson,
D. Owen,
M. L. Grant, and C. D. Gregory.
1995.
A novel protein expressed in mammalian cells undergoing apoptosis.
Exp. Cell Res.
218:439-451[CrossRef][Medline].
|
| 12.
|
Horsburgh, C. R., Jr., and W. M. Meyers.
1997.
Buruli ulcer, p. 119-134.
In
C. R. Horsburgh, Jr., and A. M. Nelson (ed.), Pathology of emerging infections. ASM Press, Washington, D.C.
|
| 13.
|
Kaushal, G. P.,
N. Ueda, and S. V. Shah.
1997.
Role of caspases (ICE/CED3 proteases) in DNA damage and cell death in response to a mitochondrial inhibitor, antimycin A.
Kidney Int.
52:438-445[Medline].
|
| 14.
|
Klinger, K.,
K. M. Tchou-Wong,
O. Brandli,
C. Aston,
R. Kim,
C. Chi, and W. N. Rom.
1997.
Effects of mycobacteria on regulation of apoptosis in mononuclear phagocytes.
Infect. Immun.
65:5272-5278[Abstract].
|
| 15.
|
Krieg, R. E.,
W. T. Hockmeyer, and D. H. Connor.
1974.
Toxin of Mycobacterium ulcerans.
Arch. Dermatol.
110:783-788[Abstract/Free Full Text].
|
| 16.
|
Li, B.,
H. Bassiri,
M. D. Rossman,
P. Kramer,
A. F. Eyuboglu,
M. Torres,
E. Sada,
T. Imir, and S. R. Carding.
1998.
Involvement of the Fas/Fas ligand pathway in activation-induced cell death of mycobacteria-reactive human  T cells: a mechanism for the loss of  T cells in patients with pulmonary tuberculosis.
J. Immunol.
161:1558-1567[Abstract/Free Full Text].
|
| 17.
|
Long, X.,
M. T. Crow,
S. J. Sollott,
L. O'Neil,
D. S. Menees,
M. D. Hipolito,
M. O. Boluyt,
T. Asai, and E. G. Lakatta.
1998.
Enhanced expression of p53 and apoptosis induced by blockade of the vacuolar proton ATPase in cardiomyocytes.
J. Clin. Investig.
101:1453-1461[Medline].
|
| 18.
|
McCallum, P.,
J. C. Tolhurst,
G. Buckle,
H. A. Sissons,
G. Buckle, and J. C. Tolhurst.
1948.
A new mycobacterial infection in man.
J. Pathol. Bacteriol.
60:93-122[CrossRef][Medline].
|
| 19.
|
Molloy, A.,
P. Laochumroonvorapong, and G. Kaplan.
1994.
Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Geurin.
J. Exp. Med.
180:1499-1509[Abstract/Free Full Text].
|
| 20.
|
Mulvey, M. A.,
Y. S. Lopez-Boado,
C. L. Wilson,
R. Roth,
W. C. Parks,
J. Heuser, and S. J. Hultgren.
1998.
Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli.
Science
282:1494[Abstract/Free Full Text].
|
| 21.
|
Oberhammer, F.,
J. W. Wilson,
C. Dive,
I. D. Morris,
J. A. Hickman,
A. E. Wakeling,
P. R. Walker, and M. Sikorska.
1993.
Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation.
EMBO J.
12:3679-3684[Medline].
|
| 22.
|
Ormerod, M. G.,
C. F. O'Neill,
D. Robertson, and K. R. Harrap.
1994.
Cisplatin induces apoptosis in a human ovarian carcinoma cell line without concomitant internucleosomal degradation of DNA.
Exp. Cell Res.
211:231-237[CrossRef][Medline].
|
| 23.
|
Pahlevan, A. A.,
D. J. Wright,
K. M. George,
P. L. Small, and B. M. Foxwell.
1999.
The inhibitory action of Mycobacterium ulcerans soluble factor on monocyte/T cell functions and expression of NF B.
J. Immunol.
163:3928-3935[Abstract/Free Full Text].
|
| 24.
|
Re, F.,
A. Zanetti,
M. Sironi,
N. Polentarutti,
L. Lanfrancone,
E. Dejana, and F. Colotta.
1994.
Inhibition of anchorage-dependent cell spreading triggers apoptosis in culture human endothelial cells.
J. Cell Biol.
127:537-546[Abstract/Free Full Text].
|
| 25.
|
Read, J. K.,
C. M. Heggie,
W. M. Meyers, and D. H. Connor.
1974.
Cytotoxic activity of Mycobacterium ulcerans.
Infect. Immun.
9:1114-1122[Abstract/Free Full Text].
|
| 26.
|
Rojas, M.,
L. F. Barrera,
G. Puzo, and L. F. Garcia.
1997.
Differential induction of apoptosis by virulent Mycobacterium tuberculosis in resistant and susceptible murine macrophages: role of nitric oxide and mycobacterial products.
J. Immunol.
159:1352-1361[Abstract].
|
| 27.
|
Sarin, A.,
M.-L. Wu, and P. A. Henkart.
1996.
Different interleukin-1 -converting enzyme (ICE) family protease requirements for the apoptotic death of T lymphocytes triggered by diverse stimuli.
J. Exp. Med.
184:2445-2450[Abstract/Free Full Text].
|
| 28.
|
Sauman, I., and S. J. Berry.
1993.
Cytochalasin-D treatment triggers premature apoptosis of insect ovarian follicle and nurse cells.
Int. J. Dev. Biol.
37:441-450[Medline].
|
| 29.
|
Schulz-Osthoff, K.,
H. Walczak,
W. Droge, and P. H. Krammer.
1994.
Cell nucleus and DNA fragmentation are not required for apoptosis.
J. Cell Biol.
127:15-20[Abstract/Free Full Text].
|
| 30.
|
Scott, G.,
L. Cassidy, and A. Busacco.
1997.
Fibronectin supresses apoptosis in normal human melanocytes through an integrin-dependent mechanism.
J. Investig. Dermatol.
108:147-153[CrossRef][Medline].
|
| 31.
|
Sugai, M.,
T. Kawamoto,
S. Y. Peres,
Y. Ueno,
H. Komatsuzawa,
T. Fujiwara,
H. Kurihara,
H. Suginaka, and E. Oswald.
1998.
The cell cycle-specific growth-inhibitory factor produced by Actinobacillus actinomycetemcomitans is a cytolethal distending toxin.
Infect. Immun.
66:5008-5019[Abstract/Free Full Text].
|
| 32.
|
Vercammen, D.,
G. Brouckaert,
G. Denecker,
M. Van de Craen,
W. Declercq,
W. Fiers, and P. Vandenabeele.
1998.
Dual signaling of the fas receptor: initiation of both apoptotic and necrotic cell death pathways.
J. Exp. Med.
188:919-930[Abstract/Free Full Text].
|
Infection and Immunity, February 2000, p. 877-883, Vol. 68, No. 2
0019-9567/00/$04.00+0
This article has been cited by other articles:
-
Simmonds, R. E., Lali, F. V., Smallie, T., Small, P. L. C., Foxwell, B. M.
(2009). Mycolactone Inhibits Monocyte Cytokine Production by a Posttranscriptional Mechanism. J. Immunol.
182: 2194-2202
[Abstract]
[Full Text]
-
Sarfo, F. S., Phillips, R. O., Ampadu, E., Sarpong, F., Adentwe, E., Wansbrough-Jones, M.
(2009). Dynamics of the Cytokine Response to Mycobacterium ulcerans during Antibiotic Treatment for M. ulcerans Disease (Buruli Ulcer) in Humans. CVI
16: 61-65
[Abstract]
[Full Text]
-
En, J., Goto, M., Nakanaga, K., Higashi, M., Ishii, N., Saito, H., Yonezawa, S., Hamada, H., Small, P. L. C.
(2008). Mycolactone Is Responsible for the Painlessness of Mycobacterium ulcerans Infection (Buruli Ulcer) in a Murine Study. Infect. Immun.
76: 2002-2007
[Abstract]
[Full Text]
-
Chauty, A., Ardant, M.-F., Adeye, A., Euverte, H., Guedenon, A., Johnson, C., Aubry, J., Nuermberger, E., Grosset, J.
(2007). Promising Clinical Efficacy of Streptomycin-Rifampin Combination for Treatment of Buruli Ulcer (Mycobacterium ulcerans Disease). Antimicrob. Agents Chemother.
51: 4029-4035
[Abstract]
[Full Text]
-
Torrado, E., Adusumilli, S., Fraga, A. G., Small, P. L. C., Castro, A. G., Pedrosa, J.
(2007). Mycolactone-Mediated Inhibition of Tumor Necrosis Factor Production by Macrophages Infected with Mycobacterium ulcerans Has Implications for the Control of Infection. Infect. Immun.
75: 3979-3988
[Abstract]
[Full Text]
-
Coutanceau, E., Decalf, J., Martino, A., Babon, A., Winter, N., Cole, S. T., Albert, M. L., Demangel, C.
(2007). Selective suppression of dendritic cell functions by Mycobacterium ulcerans toxin mycolactone. JEM
204: 1395-1403
[Abstract]
[Full Text]
-
WALSH, D. S., DELA CRUZ, E. C., ABALOS, R. M., TAN, E. V., WALSH, G. P., PORTAELS, F., MEYERS, W. M.
(2007). CLINICAL AND HISTOLOGIC FEATURES OF SKIN LESIONS IN A CYNOMOLGUS MONKEY EXPERIMENTALLY INFECTED WITH MYCOBACTERIUM ULCERANS (BURULI ULCER) BY INTRADERMAL INOCULATION. Am J Trop Med Hyg
76: 132-134
[Abstract]
[Full Text]
-
Diaz, D., Dobeli, H., Yeboah-Manu, D., Mensah-Quainoo, E., Friedlein, A., Soder, N., Rondini, S., Bodmer, T., Pluschke, G.
(2006). Use of the Immunodominant 18-Kilodalton Small Heat Shock Protein as a Serological Marker for Exposure to Mycobacterium ulcerans. CVI
13: 1314-1321
[Abstract]
[Full Text]
-
Ranger, B. S., Mahrous, E. A., Mosi, L., Adusumilli, S., Lee, R. E., Colorni, A., Rhodes, M., Small, P. L. C.
(2006). Globally Distributed Mycobacterial Fish Pathogens Produce a Novel Plasmid-Encoded Toxic Macrolide, Mycolactone F. Infect. Immun.
74: 6037-6045
[Abstract]
[Full Text]
-
Rondini, S., Mensah-Quainoo, E., Junghanss, T., Pluschke, G.
(2006). What Does Detection of Mycobacterium ulcerans DNA in the Margin of an Excised Buruli Ulcer Lesion Tell Us?. J. Clin. Microbiol.
44: 4273-4275
[Abstract]
[Full Text]
-
Yeboah-Manu, D., Peduzzi, E., Mensah-Quainoo, E., Asante-Poku, A., Ofori-Adjei, D., Pluschke, G., Daubenberger, C. A.
(2006). Systemic suppression of interferon-{gamma} responses in Buruli ulcer patients resolves after surgical excision of the lesions caused by the extracellular pathogen Mycobacterium ulcerans. J. Leukoc. Biol.
79: 1150-1156
[Abstract]
[Full Text]
-
Goto, M., Nakanaga, K., Aung, T., Hamada, T., Yamada, N., Nomoto, M., Kitajima, S., Ishii, N., Yonezawa, S., Saito, H.
(2006). Nerve Damage in Mycobacterium ulcerans-Infected Mice: Probable Cause of Painlessness in Buruli Ulcer. Am. J. Pathol.
168: 805-811
[Abstract]
[Full Text]
-
Phillips, R., Horsfield, C., Kuijper, S., Sarfo, S. F., Obeng-Baah, J., Etuaful, S., Nyamekye, B., Awuah, P., Nyarko, K. M., Osei-Sarpong, F., Lucas, S., Kolk, A. H. J., Wansbrough-Jones, M.
(2006). Cytokine Response to Antigen Stimulation of Whole Blood from Patients with Mycobacterium ulcerans Disease Compared to That from Patients with Tuberculosis. CVI
13: 253-257
[Abstract]
[Full Text]
-
Oliveira, M. S., Fraga, A. G., Torrado, E., Castro, A. G., Pereira, J. P., Filho, A. L., Milanezi, F., Schmitt, F. C., Meyers, W. M., Portaels, F., Silva, M. T., Pedrosa, J.
(2005). Infection with Mycobacterium ulcerans Induces Persistent Inflammatory Responses in Mice. Infect. Immun.
73: 6299-6310
[Abstract]
[Full Text]
-
WALSH, D. S., MEYERS, W. M., PORTAELS, F., LANE, J. E., MONGKOLSIRICHAIKUL, D., HUSSEM, K., GOSI, P., MYINT, K. S. A.
(2005). HIGH RATES OF APOPTOSIS IN HUMAN MYCOBACTERIUM ULCERANS CULTURE-POSITIVE BURULI ULCER SKIN LESIONS. Am J Trop Med Hyg
73: 410-415
[Abstract]
[Full Text]
-
Wansbrough-Jones, M., Phillips, R.
(2005). Buruli ulcer. BMJ
330: 1402-1403
[Full Text]
-
Mve-Obiang, A., Lee, R. E., Umstot, E. S., Trott, K. A., Grammer, T. C., Parker, J. M., Ranger, B. S., Grainger, R., Mahrous, E. A., Small, P. L. C.
(2005). A Newly Discovered Mycobacterial Pathogen Isolated from Laboratory Colonies of Xenopus Species with Lethal Infections Produces a Novel Form of Mycolactone, the Mycobacterium ulcerans Macrolide Toxin. Infect. Immun.
73: 3307-3312
[Abstract]
[Full Text]
-
Stinear, T. P., Hong, H., Frigui, W., Pryor, M. J., Brosch, R., Garnier, T., Leadlay, P. F., Cole, S. T.
(2005). Common Evolutionary Origin for the Unstable Virulence Plasmid pMUM Found in Geographically Diverse Strains of Mycobacterium ulcerans. J. Bacteriol.
187: 1668-1676
[Abstract]
[Full Text]
-
Prevot, G., Bourreau, E., Pascalis, H., Pradinaud, R., Tanghe, A., Huygen, K., Launois, P.
(2004). Differential Production of Systemic and Intralesional Gamma Interferon and Interleukin-10 in Nodular and Ulcerative Forms of Buruli Disease. Infect. Immun.
72: 958-965
[Abstract]
[Full Text]
-
Marsollier, L., Stinear, T., Aubry, J., Saint Andre, J. P., Robert, R., Legras, P., Manceau, A.-L., Audrain, C., Bourdon, S., Kouakou, H., Carbonnelle, B.
(2004). Aquatic Plants Stimulate the Growth of and Biofilm Formation by Mycobacterium ulcerans in Axenic Culture and Harbor These Bacteria in the Environment. Appl. Environ. Microbiol.
70: 1097-1103
[Abstract]
[Full Text]
-
Daniel, A. K., Lee, R. E., Portaels, F., Small, P. L. C.
(2004). Analysis of Mycobacterium Species for the Presence of a Macrolide Toxin, Mycolactone. Infect. Immun.
72: 123-132
[Abstract]
[Full Text]
-
Lamichhane, G., Zignol, M., Blades, N. J., Geiman, D. E., Dougherty, A., Grosset, J., Broman, K. W., Bishai, W. R.
(2003). A postgenomic method for predicting essential genes at subsaturation levels of mutagenesis: Application to Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA
100: 7213-7218
[Abstract]
[Full Text]
-
Mve-Obiang, A., Lee, R. E., Portaels, F., Small, P. L. C.
(2003). Heterogeneity of Mycolactones Produced by Clinical Isolates of Mycobacterium ulcerans: Implications for Virulence. Infect. Immun.
71: 774-783
[Abstract]
[Full Text]
-
Marsollier, L., Robert, R., Aubry, J., Saint Andre, J.-P., Kouakou, H., Legras, P., Manceau, A.-L., Mahaza, C., Carbonnelle, B.
(2002). Aquatic Insects as a Vector for Mycobacterium ulcerans. Appl. Environ. Microbiol.
68: 4623-4628
[Abstract]
[Full Text]
-
Dobos, K. M., Small, P. L., Deslauriers, M., Quinn, F. D., King, C. H.
(2001). Mycobacterium ulcerans Cytotoxicity in an Adipose Cell Model. Infect. Immun.
69: 7182-7186
[Abstract]
[Full Text]
-
Gooding, T. M., Johnson, P. D. R., Campbell, D. E., Hayman, J. A., Hartland, E. L., Kemp, A. S., Robins-Browne, R. M.
(2001). Immune Response to Infection with Mycobacterium ulcerans. Infect. Immun.
69: 1704-1707
[Abstract]
[Full Text]